Physician profile
Edgar Daniel Ramirez
NPI 1548242399
$14,894.55
in general payments reported to CMS, 2019-2025
51 companies · $3,047 in 2025
The $3,047 reported for 2025 was more than what 86% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,070 · 2020: $922 · 2021: $1,344 · 2022: $2,661 · 2023: $2,925 · 2024: $2,926 · 2025: $3,047.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,402 · Travel and Lodging: $1,419 · Education: $77.51.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,401.60 |
| Travel and Lodging | $1,419.06 |
| Education | $77.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $2,933.45 | 2022-2023 | Intracept |
| Boston Scientific Corporation | $2,222.05 | 2022-2025 | Intracept, Wavewriter Alpha Prime 16, Intracept Rf Probe |
| Spinal Simplicity, LLC | $1,942.24 | 2024-2025 | Ha Minuteman G3-R, Liberty Si |
| Collegium Pharmaceutical, INC. | $982.13 | 2019-2025 | Xtampza |
| Abbvie INC. | $734.76 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $695.86 | 2019-2025 | Relistor |
| Allergan, INC. | $541.02 | 2019-2022 | |
| Pfizer INC. | $419.35 | 2019-2025 | |
| Saluda Medical Americas, INC. | $409.67 | 2023-2024 | Evoke Scs, Evoke |
| Teva Pharmaceuticals USA, INC. | $376.13 | 2019-2023 | Ajovy |
| Scilex Pharmaceuticals INC. | $361.16 | 2019-2024 | Ztlido |
| Protega Pharmaceutials INC | $238.93 | 2022-2025 | Roxybond |
| Upsher-Smith Laboratories LLC | $238.55 | 2019-2023 | |
| Vertos Medical, INC. | $231.31 | 2022-2024 | Mild Device Kit |
| Nevro Corp. | $227.47 | 2019-2024 | Senza |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $220.61 | 2021-2024 | Proclaim |
| Supernus Pharmaceuticals, INC. | $181.34 | 2019-2020 | |
| Painteq LLC | $162.55 | 2023 | Painteq |
| Curonix LLC | $162.35 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Novartis Pharmaceuticals Corporation | $160.25 | 2019-2021 | |
| Stimwave Technologies Incorporated | $151.12 | 2019-2020 | |
| Lilly USA, LLC | $133.51 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $124.59 | 2021 | |
| Amgen INC. | $119.53 | 2019-2024 | Krystexxa |
| Fidia Pharma USA INC. | $111.68 | 2020-2024 | Hymovis, Triluron, Hyalgan |
| Pacira Pharmaceuticals Incorporated | $68.87 | 2023-2024 | Iovera, Zilretta, Exparel |
| Globus Medical, INC. | $65.56 | 2025 | Senza |
| Ibsa Pharma INC. | $59.56 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $47.62 | 2022 | |
| Almatica Pharma LLC | $43.87 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $43.00 | 2025 | |
| Atland Pharmaceuticals, LLC | $42.34 | 2024-2025 | Orphenadrine Citrate, Aspirin and Caffeine, Tolmetin Sodium |
| Si-Bone, INC. | $42.05 | 2024-2025 | |
| Medtronic, INC. | $41.85 | 2022-2024 | Intellis Adaptivestim |
| Nalu Medical, INC. | $40.38 | 2021-2025 | Nalu Neurostimulation System |
| Bioventus LLC | $34.49 | 2021-2022 | |
| Daiichi Sankyo INC. | $31.70 | 2019 | |
| Spr Therapeutics, INC | $26.21 | 2024 | Sprint Pns System |
| Stryker Corporation | $24.36 | 2025 | Optablate |
| Medtronic USA, INC. | $21.50 | 2020 | |
| Averitas Pharma INC. | $20.37 | 2024 | Qutenza |
| Valinor Pharma, LLC | $19.92 | 2025 | Movantik |
| Idorsia Pharmaceuticals US INC | $18.99 | 2023 | Quviviq |
| Horizon Therapeutics Plc | $18.84 | 2022 | |
| International Rehabilitative Sciences, INC | $17.85 | 2024 | Rs 4i Plus Sequential Stimulator |
| Indivior INC. | $16.88 | 2019 | |
| Breg, INC | $14.95 | 2021 | |
| Orthogenrx INC. | $14.91 | 2020 | |
| Biodelivery Sciences International, INC. | $14.46 | 2021 | |
| Baudax Bio INC. | $12.79 | 2020 | |
| Foundation Fusion Solutions, LLC | $9.62 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edgar Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.